Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

NanoKTN Announces Start of UK NanoRegen Mission to Germany and Austria

Published: Thursday, September 06, 2012
Last Updated: Thursday, September 06, 2012
Bookmark and Share
Raising the profile of UK nanotechnology capabilities in regenerative medicine.

The Nanotechnology Knowledge Transfer Network has announced the start of the NanoRegen Mission 2012, which is taking a delegation of six UK companies and academics specialised in developing materials for use in tissue engineering and regenerative medicine to Austria and Germany. The mission, organised in partnership with the Science and Innovation Network, Berlin and Chemistry Innovation KTN, aims to raise the profiles of UK companies abroad and help foster links with overseas suppliers and potential customers, ensuring the future of UK nanotechnology is embedded in the global market.

The UK, Germany and Austria all have significant expertise within the multidisciplinary field of regenerative medicine, but to ensure further product development and commercialisation, the convergence and co-operation of companies and academics alike is required. The mission provides an opportunity for UK companies and academic institutions to engage with key personnel and groups from Germany and Austria, with the aim of finding collaborators with whom new ideas can be formed and thus challenges solved.

The Mission is being led by Professor Chris Mason, Head of the Regenerative Medicine Bioprocess Group in the Advanced Centre for Biochemical Engineering at UCL, who will be joined by a UK delegation comprising of The Electrospinning Company, Giltech Ltd, Neotherix, Orla Protein Technologies Ltd, Pharmidex and University of Oxford. Each delegate will be given the opportunity to speak at the workshops arranged at the Fraunhofer IZI, Leipzig and the British Embassy, Berlin. The NanoRegen Mission will conclude with attendance at the 3rd TERMIS World Congress.

“International missions are hugely valuable to UK SMEs and academics. At the NanoKTN we support the exploitation and commercialisation of nanotechnologies and the aim of this mission is to help UK SMEs explore what is available in Germany and Austria. The four day mission will provide a major networking opportunity and platform for the UK delegation to present its work and we are sure it will see the same success we have seen with past missions,” says Dr Alec Reader, Director at the NanoKTN.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

NanoKTN Supports Regenerative Medicine Development
UK Regenerative Medicine Platform (UKRMP) Safety Hub announced.
Wednesday, May 08, 2013
Scientific News
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Skin Cells Turned into Heart Cells and Brain Cells Using Drugs
In a scientific first, Gladstone researchers have used chemical drugs to convert skin cells into heart cells and brain cells, without adding any external genes.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Micro Heart Muscle Created from Stem Cells
Researchers have designed a new way to create micro heart muscle from stem cells using a unique dog bone dish.
Immune Booster Tested in Advanced Merkel Cell Cancer
The immunotherapy drug produced durable responses in many patients.
Mutated Mitochondria Found in Stem Cells
Researchers find hidden genetic mutations in patient-derived stem cells which could ultimately undermine therapeutic benefit.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!